Monday, December 5, 2022

Molecular Partners in the black

by admin
0 comment

According to a statement from MP on Thursday evening, the company achieved sales of CHF 182.8 million, mainly thanks to the payment from pharmaceutical giant Novartis. At operational level, there was a profit of CHF 152.6 million and the bottom line was a net profit of CHF 153.1 million. In the first quarter of last year, MP still had a loss of more than 18 million.

Since the company does not yet have any of its own drugs on the market, it is currently “burning” money – at least if the financial injection from the pharmaceutical giant is ignored. Accordingly, liquid funds are also important. Molecular Partners estimates this at CHF 296.2 million.

Related News

Latest Switzerland News and updates and political news, follow our daily update about the congress and the government roundup, we also provide the latest news from all over the world minute by minute, subscribe to get the latest updates directly to your inbox.

© 2022 All Right Reserved. Switzerland Times